| Prev Close | 54.80 |
| Open | 55.20 |
| Day Low/High | 54.22 / 55.31 |
| 52 Wk Low/High | 36.15 / 64.94 |
| Volume | 3.20M |
Astrazeneca PLC Sponsored ADR (AZN)
54.36
0.44
0.80
NASDAQ
| Exchange | NASDAQ |
| P/E Ratio | 53.50 |
| Div & Yield | N.A. (N.A) |
Latest News
Stock-Specific Ideas for the Post-Fed Era of Investing
Make sure that your portfolio is composed of sane assets for the balance of this crazy year.
Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff
Electoral risk remains the monster under the bed, and it only grows as our legislators intentionally choose the blame game over honest cooperation.
Jim Cramer: These Stocks Show the Market's Betting on a Vaccine
The prices of hotels and even beaten up retailers say that many believe a vaccine is on the way -- here's how I would get positioned.
How About That Merck and Seattle Genetics Deal?
I am long Merck, not Seattle Genetics, though the one to own now is obviously SGEN.
Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update
Also, several scheduled events this week, election risk, earnings to watch.
This Biotech Appears to Have the Right Formula for Investors
After reviewing the rally, let's zero in on one biotech name, Genprex, and where it appears to be going.
My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone
This writer is rooting for the success of all efforts to halt the spread of the virus as he struggles with the aftereffects of the disease.
Last Night I Took Short-Term Rental Longs in SPY, QQQ
* On counter punching * And being opportunistic, flexible and unemotional As you all recognize I work off an investment thesis, the foundation of which typically is the relationship of a stock, a sector or an Index to my calculation of "fair market ...
No Rotation, No Panic, Nasdaq's Crucial Line, Tesla's Truly Bad Day, Apple Stung
We must see equity markets, the Nasdaq Composite and Nasdaq 100 in particular, fight back this week to keep on believing in this market.
That Stings: AZN Vaccine Trial Reportedly on Hold
"Just one more thing." - Lt. Columbo Statnews.com is reporting that the phase 3 study for AstraZeneca's Covid-19 vaccine is put on hold.
Moderna and AstraZeneca Could Use a Shot in the Arm
An effective Covid-19 will be a game-changer, but charts say the bottom-line impact may not be as significant as previously believed.
Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon
Plus, reading tea leaves in the recent action in Apple and Salesforce.com.
A Healthy Dose of Vaccine and Pharmaceutical Plays
6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?
Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'
The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J
The equity market recovery is just as sloppy in performance as the economy itself.
Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon
It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.
Across the Pond: 5 ETFs for European Equity Exposure
European markets have been slumping for years, but the time for those countries to shine again may finally be around the corner.
Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.
Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment
The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.
Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed
Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.
Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers
Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.
Jim Cramer: We Have Now Developed a Truly Roulette Market
You can bet on black, which is instant vaccine, or you can bet on red, which is the shutdown non-economy. Both have variants.
AstraZeneca Could Continue to Higher Highs
Oxford University, along with Britain's AstraZeneca, published promising data from an early stage trial of a key coronavirus vaccine study Monday in London.
If You Can Trade These Markets, You Can Survive in Almost Any Environment
If you are out of step with the marketplace, do not blame the marketplace. Understand that you have failed to adapt.
Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know
Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.
Novavax and Its $1.6 Billion Award Just Got My Attention
The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.
Q2 Earnings Expectations, Phase 3 Vaccine Clinical Trials, Unemployment Numbers
What if the market is simply pricing in a quarter that had already been priced out?
AstraZeneca Has Its Act and Its Charts 'Together'
Let's review the charts and indicators.
